Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium

• Published in: BMC psychiatry Vol. 13; no. 1; p. 240
• Main Authors: Yoon, Hyung-Jun, Park, Kyoung-Min, Choi, Won-Jung, Choi, Soo-Hee, Park, Jin-Young, Kim, Jae-Jin, Seok, Jeong-Ho
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.09.2013; BioMed Central
• Subjects: Aged; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Antipsychotic drugs; Benzodiazepines - adverse effects; Benzodiazepines - therapeutic use; Comparative analysis; Delirium; Delirium - drug therapy; Dibenzothiazepines - adverse effects; Dibenzothiazepines - therapeutic use; Drug therapy; Female; Haloperidol - adverse effects; Haloperidol - therapeutic use; Health aspects; Hospitalization; Humans; Male; Medical research; Medicine, Experimental; Middle Aged; Olanzapine; Prospective Studies; Psychiatry; Psychotropic drugs; Quetiapine Fumarate; Risperidone - adverse effects; Risperidone - therapeutic use; Studies; Treatment Outcome; United States
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/1471-244X-13-240

Most previous studies on the efficacy of antipsychotic medication for the treatment of delirium have reported that there is no significant difference between typical and atypical antipsychotic medications. It is known, however, that older age might be a predictor of poor response to antipsychotics i...